Raia Drogasil (RADLY) Stock Price, News & Analysis

Company Overview

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Key Stats

• Today's Range: $2.80 to $2.81
• 50-Day Range: $2.71 to $3.91
• 52-Week Range: $2.59 to $14.00
• Volume: 1,196 shs
• Average Volume: 5,678 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RADLY Stock Analysis - Frequently Asked Questions

How have RADLY shares performed this year?

Raia Drogasil's stock was trading at $3.25 at the beginning of 2025. Since then, RADLY shares have decreased by 13.8% and is now trading at $2.80.
View the best growth stocks for 2025 here.

When did Raia Drogasil's stock split?

Raia Drogasil's stock split before market open on Monday, May 22nd 2023. The 26-25 split was announced on Monday, May 22nd 2023. The newly created shares were payable to shareholders after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split.

How do I buy shares of Raia Drogasil?

Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Record date for 6/9 Dividend: 12/12/2024
• Ex-Dividend for 6/9 Dividend: 12/12/2024
• Today: 5/10/2025
• Dividend Payable: 6/09/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RADLY
• CIK: N/A
• Web: www.rd.com.br
• Phone: 551137695678
• Fax: N/A
• Employees: 57,708
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A